Cytodyn Inc (CYDY)

[Amatuer17]

One of the big red flag for me has been the delay in enrollment - the adjunct therapy needed 300 patients - then criteria was relaxed - then no of patients required was reduced to 150 - then another ask for relaxation and not ask for reduction of patients

Look at other HIV trials by GILD and VIIV - they are getting patients and progressing trials with large patients fast but CYDY cannot.
Is there something wrong here?

Just waiting for FDA to reduce the no of patients and stopping recruitment is not good sign. It has delay written all over

Also - If someone expects phase 3 approval based on 30 to 50 patients - then it is unrealistic.